Yiheng Capital Management’s Generation Bio GBIO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | – | Sell |
-105,524
| Closed | -$599K | – | 26 |
|
|
2025
Q4 | $599K | Hold |
105,524
| – | – | 0.12% | 21 |
|
|
2025
Q3 | $646K | Sell |
105,524
-3
| -0% | -$16 | 0.1% | 26 |
|
|
2025
Q2 | $338K | Buy |
105,527
+86,374
| +451% | +$333K | 0.03% | 24 |
|
|
2025
Q1 | $77.6K | Hold |
19,153
| – | – | 0.01% | 25 |
|
|
2024
Q4 | $203K | Hold |
19,153
| – | – | 0.01% | 22 |
|
|
2024
Q3 | $473K | Hold |
19,153
| – | – | 0.02% | 18 |
|
|
2024
Q2 | $540K | Hold |
19,153
| – | – | 0.04% | 24 |
|
|
2024
Q1 | $780K | Buy |
+19,153
| New | +$451K | 0.04% | 22 |
|
|
2023
Q4 | – | Sell |
-166,618
| Closed | -$6.31M | – | 25 |
|
|
2023
Q3 | $6.31M | Buy |
166,618
+6,441
| +4% | +$305K | 0.32% | 27 |
|
|
2023
Q2 | $8.81M | Hold |
160,177
| – | – | 0.48% | 22 |
|
|
2023
Q1 | $6.89M | Buy |
160,177
+41,547
| +35% | +$2.01M | 0.27% | 25 |
|
|
2022
Q4 | $4.66M | Buy |
118,630
+18,844
| +19% | +$989K | 0.21% | 26 |
|
|
2022
Q3 | $5.3M | Sell |
99,786
-159,977
| -62% | -$10M | 0.33% | 25 |
|
|
2022
Q2 | $17M | Hold |
259,763
| – | – | 0.97% | 23 |
|
|
2022
Q1 | $19.1M | Buy |
259,763
+62,248
| +32% | +$3.61M | 0.87% | 23 |
|
|
2021
Q4 | $14M | Buy |
197,515
+37,538
| +23% | +$6.55M | 0.71% | 24 |
|
|
2021
Q3 | $40.1M | Buy |
159,977
+18,329
| +13% | +$4.39M | 1.97% | 17 |
|
|
2021
Q2 | $38.1M | Buy |
+141,648
| New | +$42.4M | 1.53% | 14 |
|
Other funds holding GBIO
Yiheng Capital Management's GBIO Position: Q1 2026 in Review
Yiheng Capital Management sold out of Generation Bio (GBIO) in Q1 2026, closing a stake of 105,524 shares — an estimated $599K sold.
Yiheng Capital Management first reported a position in GBIO in Q2 2021 and held it in 18 quarters. The position peaked at $40.1M in Q3 2021. 2 funds tracked by Wall St. Rank hold GBIO as of Q1 2026.
- Yiheng Capital Management reported no remaining Generation Bio position as of Q1 2026 after selling out during the quarter.
- Yiheng Capital Management sold 105,524 Generation Bio shares in Q1 2026, an estimated $599K.
- Yiheng Capital Management first reported a position in Generation Bio in Q2 2021 and held it in 18 quarters.
- Yiheng Capital Management's Generation Bio position peaked at $40.1M in Q3 2021.
- 2 funds tracked by Wall St. Rank held Generation Bio as of Q1 2026.
Based on Yiheng Capital Management's 13F filing for Q1 2026, filed 15 May 2026.